Merrimack Receives Fast Track For Pancreatic Cancer Drug
November 19, 2014 at 16:29 PM EST
The reason the FDA gave MACK Fast Track approval is because there are no current therapies for pancreatic cancer -- the drug meets an unmet medical need.